Patents Assigned to Artificial Cell Technologies, Inc.
-
Patent number: 8883717Abstract: Multilayer films comprised of polypeptide epitopes and a toll-like receptor ligand are described. The multilayer films are capable of eliciting an immune response in a host upon administration to the host. The multilayer films can include at least one designed peptide that includes one or more polypeptide epitopes from a virus, bacteria, fungus or parasite.Type: GrantFiled: March 14, 2013Date of Patent: November 11, 2014Assignee: Artificial Cell Technologies, Inc.Inventors: Thomas J. Powell, James Gorham Boyd
-
Patent number: 7973129Abstract: Disclosed herein are polypeptide multilayer films wherein a therapeutic agent is covalently linked to a first layer polypeptide. An advantage of such attachment is that the linked therapeutic agent can be controllably released from the multilayer film into the environment of the film upon the addition of a suitable stimulus. An advantage of the disclosed films and methods is enablement of environmentally-stimulated release under specific conditions.Type: GrantFiled: April 5, 2010Date of Patent: July 5, 2011Assignee: Artificial Cell Technologies, Inc.Inventor: Donald Templeton Haynie
-
Patent number: 7888316Abstract: Disclosed herein are polypeptide multilayer films comprising a hybrid polypeptide comprising a first polypeptide segment and a second segment, the two segments being covalently joined by one or more non-peptidic linkages. The first segment comprises a polypeptide having a magnitude of net charge per residue of greater than or equal to 0.4, and a length of greater than or equal to about 12 amino acid residues. The second segment comprises a polypeptide or another polyelectrolyte.Type: GrantFiled: April 9, 2010Date of Patent: February 15, 2011Assignee: Artificial Cell Technologies, Inc.Inventor: Donald T. Haynie
-
Patent number: 7807632Abstract: Disclosed herein are immunogenic compositions comprising a multilayer film comprising two or more layers of polyelectrolytes, wherein adjacent layers comprise oppositely charged polyelectrolytes. A first layer polyelectrolyte comprises an antigenic polypeptide comprising one or more surface adsorption regions covalently linked to one or more antigenic determinant regions, wherein the antigenic polypeptide and the one or more surface adsorption regions have the same polarity. The immunogenic compositions may be employed in methods of eliciting an immune response in a vertebrate organism.Type: GrantFiled: October 5, 2009Date of Patent: October 5, 2010Assignee: Artificial Cell Technologies, Inc.Inventor: Donald T. Haynie
-
Patent number: 7807633Abstract: Disclosed herein are immunogenic compositions comprising a multilayer film comprising two or more layers of polyelectrolytes, wherein adjacent layers comprise oppositely charged polyelectrolytes. A first layer polyelectrolyte comprises an antigenic polypeptide comprising one or more surface adsorption regions covalently linked to one or more antigenic determinant regions, wherein the antigenic polypeptide and the one or more surface adsorption regions have the same polarity. The immunogenic compositions may be employed in methods of eliciting an immune response in a vertebrate organism.Type: GrantFiled: October 5, 2009Date of Patent: October 5, 2010Assignee: Artificial Cell Technologies, Inc.Inventor: Donald T. Haynie
-
Patent number: 7807634Abstract: Disclosed herein are immunogenic compositions comprising a multilayer film comprising two or more layers of polyelectrolytes, wherein adjacent layers comprise oppositely charged polyelectrolytes. A first layer polyelectrolyte comprises an antigenic polypeptide comprising one or more surface adsorption regions covalently linked to one or more antigenic determinant regions, wherein the antigenic polypeptide and the one or more surface adsorption regions have the same polarity. The immunogenic compositions may be employed in methods of eliciting an immune response in a vertebrate organism.Type: GrantFiled: October 5, 2009Date of Patent: October 5, 2010Assignee: Artificial Cell Technologies, Inc.Inventor: Donald T. Haynie
-
Patent number: 7786076Abstract: Disclosed herein are immunogenic compositions comprising a multilayer film comprising two or more layers of polyelectrolytes, wherein adjacent layers comprise oppositely charged polyelectrolytes. A first layer polyelectrolyte comprises an antigenic polypeptide comprising one or more surface adsorption regions covalently linked to one or more antigenic determinant regions, wherein the antigenic polypeptide and the one or more surface adsorption regions have the same polarity. The immunogenic compositions may be employed in methods of eliciting an immune response in a vertebrate organism.Type: GrantFiled: October 5, 2009Date of Patent: August 31, 2010Assignee: Artificial Cell Technologies, Inc.Inventor: Donald T. Haynie
-
Patent number: 7781399Abstract: Disclosed herein are immunogenic compositions comprising a multilayer film comprising two or more layers of polyelectrolytes, wherein adjacent layers comprise oppositely charged polyelectrolytes. A first layer polyelectrolyte comprises an antigenic polypeptide comprising one or more surface adsorption regions covalently linked to one or more antigenic determinant regions, wherein the antigenic polypeptide and the one or more surface adsorption regions have the same polarity. The immunogenic compositions may be employed in methods of eliciting an immune response in a vertebrate organism.Type: GrantFiled: October 5, 2009Date of Patent: August 24, 2010Assignee: Artificial Cell Technologies, Inc.Inventor: Donald T. Haynie
-
Patent number: 7759305Abstract: Disclosed herein are polypeptide multilayer films wherein a therapeutic agent is covalently linked to a first layer polypeptide. An advantage of such attachment is that the linked therapeutic agent can be controllably released from the multilayer film into the environment of the film upon the addition of a suitable stimulus. An advantage of the disclosed films and methods is enablement of environmentally-stimulated release under specific conditions.Type: GrantFiled: January 22, 2008Date of Patent: July 20, 2010Assignee: Artificial Cell Technologies, Inc.Inventor: Donald Templeton Haynie
-
Patent number: 7723294Abstract: Disclosed herein are polypeptide multilayer films comprising a hybrid polypeptide comprising a first polypeptide segment and a second segment, the two segments being covalently joined by one or more non-peptidic linkages. The first segment comprises a polypeptide having a magnitude of net charge per residue of greater than or equal to 0.4, and a length of greater than or equal to about 12 amino acid residues. The second segment comprises a polypeptide or another polyelectrolyte.Type: GrantFiled: April 2, 2008Date of Patent: May 25, 2010Assignee: Artificial Cell Technologies, Inc.Inventor: Donald Templeton Haynie
-
Patent number: 7615530Abstract: Disclosed herein are immunogenic compositions comprising a multilayer film comprising two or more layers of polyelectrolytes, wherein adjacent layers comprise oppositely charged polyelectrolytes. A first layer polyelectrolyte comprises an antigenic polypeptide comprising one or more surface adsorption regions covalently linked to one or more antigenic determinant regions, wherein the antigenic polypeptide and the one or more surface adsorption regions have the same polarity. The immunogenic compositions may be employed in methods of eliciting an immune response in a vertebrate organism.Type: GrantFiled: October 25, 2006Date of Patent: November 10, 2009Assignee: Artificial Cell Technologies, Inc.Inventor: Donald T. Haynie
-
Publication number: 20080176080Abstract: Disclosed herein are polypeptide multilayer films wherein a therapeutic agent is covalently linked to a first layer polypeptide. An advantage of such attachment is that the linked therapeutic agent can be controllably released from the multilayer film into the environment of the film upon the addition of a suitable stimulus. An advantage of the disclosed films and methods is enablement of environmentally-stimulated release under specific conditions.Type: ApplicationFiled: January 22, 2008Publication date: July 24, 2008Applicant: Artificial Cell Technologies, Inc.Inventor: Donald Templeton Haynie